Chiesi Evening Symposium: "Call to action: impact of oscillometry in addressing small airways disease"
Sunday, March 24, 2024 |
5:30 PM - 7:30 PM |
Central C |
Details
Small airways disease (SAD) is a fundamental concept in both asthma and COPD, unequivocally linked to risk of exacerbations, symptom control, airway hyperresponsiveness, spirometric abnormalities and inflammation. Furthermore, SAD is evident across all severities in both obstructive diseases, often present prior to spirometric alterations and amplified in more severe disease.
Combining validated small airways measures such as oscillometry with the current industry standard spirometry is an innovative approach in obtaining valuable information which can improve disease diagnosis, management and identify phenotypes missed by current tests alone.
This session will aim to address 4 key concepts; 1. the clinical relevance and implication of SAD as a treatable trait in asthma and COPD, 2. the role of oscillometry in characterising SAD, 3. the clinical application of oscillometry and the impact of the results on diagnosis and management, 4. the addition of oscillometry as a pragmatic and new gold standard approach to target SAD and improve patient outcomes.
Speaker
Prof Bruce Thompson
Head of School - Melbourne School of Health Sciences
University of Melbourne
Session Chair
Biography
Respiratory physiologist and international expert on clinical respiratory measurement, past President of the Thoracic Society of Australia and New Zealand and current Head of the Melbourne School of Health Science, The University of Melbourne. His published works include a book on lung function, as well as numerous book chapters and 190 peer-reviewed journal articles and official documents. His international reputation has led to him being invited to participate on five American Thoracic Society/European Respiratory Society task forces and is currently a co-chair of the ATS/ERS task force writing the Lung Function interpretation document which is to be used across all lung function laboratories globally. In 2023 Prof Thompson became a Member of the Order Australia for services to respiratory medicine and medical education.
Prof Dave Singh
Professor of Clinical Pharmacology and Respiratory Medicine
University of Manchester
Call to action: impact of oscillometry in addressing small airways disease
5:35 PM - 5:55 PMBiography
Internationally renowned respiratory expert, Professor of Clinical Pharmacology and Respiratory Medicine at the University of Manchester, UK. He is also a European Respiratory Society (ERS) Gold medal winner for his outstanding contribution to COPD. His research interest is the development of new drugs for asthma and COPD. He has acted as principal investigator in over 400 clinical trials and has over 400 publications. He is a member of the Global Initiative for Chronic Obstructive Lung Disease Science Committee and was previously the chair of the ERS airway pharmacology group. He is currently an editor of the European Respiratory Journal and European Respiratory Review. He is a fellow of the European Respiratory Society and of the British Pharmacology Society.
Dr Li Ping Chung
Respiratory Specialist
Fiona Stanley Hospital
Call to action: impact of oscillometry in addressing small airways disease
5:55 PM - 6:15 PMBiography
Dr Li Ping Chung is respiratory physician with special interests in severe airways disease including asthma, COPD and non-CF bronchiectasis. Since completion of her PhD which focused on pharmacogenetics of severe asthma in 2013, she worked as a consultant at Royal Perth and Sir Charles Gairdner Hospitals. In 2015, she was appointed the clinical lead for airways disease at Fiona Stanley Hospital. She is also the Clinical Lead for Respiratory Health Network at Division of Clinical Excellence at Department of Health. Dr Chung is a member of the Australian Severe Asthma Network and actively involved in a number of Australian asthma registries, and NHMRC funded scientific and clinical research related to asthma and other airways diseases. She is currently an associate editor for the journal Frontiers of Allergy.
Prof Gregory King
Staff Specialist
Royal North Shore Hospital
Call to action: impact of oscillometry in addressing small airways disease
6:15 PM - 6:35 PMBiography
Professor King is a clinician-researcher at the Woolcock Institute of Medical Research and Professor of the Northern Clinical School of the University of Sydney. He is the research leader of the Airway Physiology and Imaging Group at the Woolcock, and is staff specialist in the Department of Respiratory Medicine at Royal North Shore Hospital, where he directs the asthma service and is the Medical Director of the Respiratory Investigation Unit. His current research interests include the pathophysiology of asthma, chronic obstructive pulmonary disease, bronchiolitis in haemopoietic stem cell transplantation, cystic fibrosis and airway hyperresponsiveness.
Dr Claude Farah
Respiratory Physician
Concord Hospital
Call to action: impact of oscillometry in addressing small airways disease
6:35 PM - 6:55 PMBiography
Associate Professor Claude Farah is an adult respiratory and sleep physician at Concord Hospital and Macquarie University Hospital, Sydney. His research interests include assessment and management of asthma and COPD, small airways disease and lung physiology. He is a member of the severe asthma registries in Australia and has co-authored position statements on respiratory oscillometry.